VOYA Investment Management
BLCM

VOYA Investment Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

VOYA Investment Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,580
Closed -$53K – 2629
2019
Q1 		$53K Hold
1,580
– – ﹤0.01% 2504
2018
Q4 		$46K Hold
1,580
– – ﹤0.01% 2499
2018
Q3 		$97K Hold
1,580
– – ﹤0.01% 2507
2018
Q2 		$117K Buy
1,580
+448
+40% +$34.9K ﹤0.01% 2492
2018
Q1 		$74K Hold
1,132
– – ﹤0.01% 2515
2017
Q4 		$95K Hold
1,132
– – ﹤0.01% 2510
2017
Q3 		$131K Hold
1,132
– – ﹤0.01% 2496
2017
Q2 		$132K Buy
+1,132
New +$141K ﹤0.01% 2515

Other funds holding BLCM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VOYA Investment Management's BLCM Position: Q2 2019 in Review

VOYA Investment Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2019, closing a stake of 1,580 shares — an estimated $53K sold.

VOYA Investment Management first reported a position in BLCM in Q2 2017 and held it in 8 quarters. The position peaked at $132K in Q2 2017. 79 funds tracked by Wall St. Rank hold BLCM as of Q2 2019.

  • VOYA Investment Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • VOYA Investment Management sold 1,580 Bellicum Pharmaceuticals, Inc. shares in Q2 2019, an estimated $53K.
  • VOYA Investment Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2017 and held it in 8 quarters.
  • VOYA Investment Management's Bellicum Pharmaceuticals, Inc. position peaked at $132K in Q2 2017.
  • 79 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2019.

Based on VOYA Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.